Northland Securities Upgrades Esperion Therapeutics to Market Perform From Underperform, Raises Price Target to $2 From $1
Northland Securities Upgrades Esperion Therapeutics to Market Perform From Underperform, Raises Price Target to $2 From $1
Northland Securities将Esperion Therapeutics的市场表现从表现不佳上调至2美元，将目标股价从1
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册